AM Newsroom callout
Informatics newsroom callout
Lab Week newsroom callout
  • news-thumbnail

    ABIM Foundation Grant to ASCP Builds Momentum for the Choosing Wisely® Campaign in California

    March 20, 2013
    ASCP was selected to receive funding by the American Board of Internal Medicine (ABIM) Foundation to help physicians engage patients in conversations aimed at reducing inappropriate tests and procedures that will improve their care and decrease costs. Support for the $50,000 grant comes from the Robert Wood Johnson Foundation and extends the efforts of the ABIM Foundation’s Choosing Wisely campaign in local communities across the United States for the next two years. Read more
  • news-thumbnail

    ASCP and the Association for Pathology Informatics Forge Alliance for Mutual Benefits

    March 07, 2013
    ASCP and the Association for Pathology Informatics (API) signed a Memorandum of Understanding (MOU) effective March 7 to collaborate on education, advocacy, and membership strategies to the mutual benefit of members from both organizations. Informatics has become an increasingly relevant component for the future of pathology and laboratory medicine. This strategic alliance enables each society to gain from each other’s areas of expertise. Read more
  • news-thumbnail

    American Society for Clinical Pathology and the Association of Clinical Scientists Join Forces to Pursue Mutual Scientific Pursuits

    January 16, 2013
    The American Society for Clinical Pathology (ASCP) and the Association of Clinical Scientists (ACS) signed a Memorandum of Understanding (MOU) effective Jan. 1 to collaborate on education, advocacy, and membership strategies to the mutual benefit of the pathologists and doctorate-level clinical scientists who belong to both medical organizations. This strategic alliance enables each organization to gain from one another’s areas of expertise. Read more
  • news-thumbnail

    ASCP Receives $434K Grant for MDS Curriculum

    January 07, 2013
    Myelodysplastic Syndromes—known as MDS—is a rare, but potentially deadly cluster of blood and bone marrow disorders that are extremely difficult to diagnose. In about one third of patients with MDS, the disease transforms into acute myelogenous leukemia (AML), usually within months to a few years. Patients who have MDS are frequently misdiagnosed or diagnosed when cancer is already in its late stages. Read more

~/Custom.Templates/NewsroomLanding.aspx